Amneal announces new data from phase 3 study showing significant improvements in sleep quality with crexont® (carbidopa and levodopa) extended-release capsules in parkinson's disease

Bridgewater, n.j.--(business wire)--new data from phase 3 study showing significant improvements in sleep quality with crexont® extended-release capsules in parkinson's disease.

AMRX Ratings Summary

AMRX Quant Ranking